Conexeu Sciences Inc.
CNXU
$10.24
-$0.72-6.57%
NASDAQ
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 38.75% | -9.91% | |||
| Depreciation & Amortization | 78.13% | -3.03% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 37.72% | -10.00% | |||
| Operating Income | -37.72% | 10.00% | |||
| Income Before Tax | -34.06% | 8.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.06% | 8.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.06% | 8.42% | |||
| EBIT | -37.72% | 10.00% | |||
| EBITDA | -37.57% | 10.02% | |||
| EPS Basic | -30.84% | 16.81% | |||
| Normalized Basic EPS | -30.84% | 16.80% | |||
| EPS Diluted | -30.84% | 16.81% | |||
| Normalized Diluted EPS | -30.84% | 16.80% | |||
| Average Basic Shares Outstanding | 2.43% | 10.05% | |||
| Average Diluted Shares Outstanding | 2.43% | 10.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||